LONDON, ENGLAND / ACCESSWIRE / December 2, 2016 / GW Pharmaceuticals plc (NASDAQ: GWPH) will host a conference call and live webcast to discuss the results of the fourth quarter 2016, to be held Monday, December 5, 2016 at 8:00 AM Eastern Time.
Live Event Information:
- Date, Time: December 5, 2016 at 8:00 AM ET
- Live Webcast: http://www.investorcalendar.com/IC/CEPage.asp?ID=175487 or www.gwpharm.com
About GW Pharmaceuticals plc
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex® (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, Tuberous Sclerosis Complex and ... read more at: http://www.baystreet.ca/viewarticle.aspx?id=450171
... read more at: http://www.baystreet.ca/viewarticle.aspx?id=450171